A Randomized, Multi-center, Parallel Group, Double Blind, Study to Assess the Safety of QMF Twisthaler (500/400 microg) and Mometasone Furoate Twisthaler (400 microg) in Adolescent and Adult Patients With Persistent Asthma.
Phase of Trial: Phase II
Latest Information Update: 04 Mar 2017
At a glance
- Drugs Indacaterol/mometasone (Primary) ; Mometasone
- Indications Asthma
- Focus Pharmacogenomic; Therapeutic Use
- 05 Sep 2012 Efficacy results presented at the 22nd Annual Congress of the European Respiratory Society.
- 05 Sep 2012 Efficacy and tolerability results presented at the 22nd Annual Congress of the European Respiratory Society.
- 04 Jun 2012 Actual patient number changed from 1500 to 2283 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History